A baby, treated with a pioneering CRISPR gene-editing therapy at Children's Hospital of Philadelphia, has taken first steps. The therapy appears to be a world-first, personalized treatment for a rare disorder, with reports suggesting it has shown promise in treating the condition. However, it is unclear if this treatment is related to other reported uses of gene editing, such as for blood cancer or in-utero treatments.